Reporting Season Round Up: Leading the charge was Playside - the ASX's local games developer

Today’s top stock was Playside Studios (ASX:PLY), the only ASX listed e-sports developer that’s based in Australia.

Playside Studios (ASX:PLY)

Playside is also the newest listed ASX company in this space, debuting last December at 20 cents a share.

Shares have never traded below that point and are more than triple its IPO price.

Today, Playside reported record quarterly revenues of $4.04 million – 114% up on 12 months ago and 29% from the prior quarter.

The company also completed its first ever acquisition during the quarter and signed a strategic partnership with global games publisher Team17.

Playside’s CEO Gerry Sakkas said it was positioned extremely well to achieve a strong FY22.

Playside (ASX:PLY) share price chart

Clean Teq (ASX:CNQ)

Clean Teq meanwhile is in the water treatment space and recently de-merged from Sunrise Energy Metals.

Its cash receipts were only $1.6 million but this was up from just $252,000 in last year’s September quarter.

Clean Teq also signed several new contracts, one was a $1.6 million contract to deliver an EVAPX system (which evaporates water from wastewater which reduces wastewater volume) to treat wastewater an recover clean water at a NSW agriculture by-product processing facility.

Another was a $3 million contract to install a HIROX (High Recovery Reverse Osmosis) plant to treat bore water used for oil recovery in the Middle East.

Clean Teq (ASX:CNQ) share price chart

Harris Technology (ASX:HT8)

While the past few quarterly reporting periods have seen many ecommerce outlets lose ground, this time has been different and Harris Technology continued the trend.

Harris reported $15.1 million in sales, up 54% from the $9.8 million made in the September quarter.

The company also boasted of achieving top seller rating on Amazon Australia where it achieved 100% positive customer reviews.

Harris Technology (ASX:HT8) share price chart

MedAdvisor (ASX:MDR)

MedAdvisor’s offers a “virtual pharmacist” service that allows customers to organise their medication and scripts via smartphone.

It made $15.4 million in revenue, up 36.5% from the prior corresponding period, $12.1 million of which was in the US.

The company is tipping $59-$60 million in revenue for the calendar year and says it was well positioned for the coming quarter which is traditionally the strongest of the year.

MedAdvisor (ASX:MDR) share price chart

4D Medical (ASX:4DX)

4D Medical is a medtech company specialising in lung imaging.

During the quarter it signed its first pharmaceutical-focused contract with Novartis to commercially use its XV software.

It also completed a clinical pilot with I-MED Radiology Network in Victoria.

The company spent $8.2 million of cash in the quarter, and closed out September with a $72.2 million cash balance.

Reporting Season Round Up: Leading the charge was Playside – the ASX’s local games developer